跳至主要内容
临床试验/NCT05252065
NCT05252065Unknown不适用

Cardiac Substructure Radiation Dose and Early Clinical Monitoring of Stage N2-3 Non-Small Cell Lung Cancer Treated With Conventional Radiotherapy

Guizhou Medical University0 个研究点目标入组 40 人开始时间: 2022年2月28日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
40
主要终点
Global longitudinal strain value

研究概览

简要总结

Calculating which cardiac substructure accepting with the highest radiation dose by conventional radiotherapy, then to investigate the relationship between the changes of global longitudinal strain or cardiac magnetic resonance imaging and cardiac biomarkers and the certain cardiac substructure for stage N2-3 non-small cell lung cancer

详细描述

All patients receive intensity-modulated radiotherapy (IMRT). The prescription dose of PTV is 60-70Gy,Troponin I, troponin T, hypersensitive troponin, brain natriuretic peptide and NT-proBNP are detected before radiotherapy, at the end of radiotherapy (day 15), at the end of radiotherapy and at 1 month after radiotherapy. Echocardiography was performed before radiotherapy, in the middle of radiotherapy (day 15) and at the end of radiotherapy to obtain global longitudinal strain value. Cardiac magnetic resonance imaging is used to measure the blood flow of the anterior descending coronary artery before and at the end of radiotherapy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients at TNM stage N2-N3 NSCLC confirmed by histopathology or cytology using IASLC International TNM staging standard (8th edition)
  • KPS score >80; Aged 18 to 75 year-old
  • No contraindications to radiotherapy
  • No history of heart disease before treatment
  • Patients receiving intensity modulated radiation therapy (IMRT)
  • Patients receiving PTV at a prescription dose of 60-70Gy by IMRT
  • Patients receiving radiotherapy alone and concurrent chemoradiotherapy

排除标准

  • Patients with pleural effusion
  • Patients with serious medical illness or infection
  • Patients with acute myocardial infarction within 6 months
  • In patients with NYHA grade 3-4, baseline LVEF before radiotherapy is below 59%
  • Patients with congenital heart diseases, valvular diseases and arrhythmia
  • Patients with pericardial effusion
  • Patients receiving immunotherapy and drug targeted therapy
  • Patients with a history of anthracycline use

结局指标

主要结局

Global longitudinal strain value

时间窗: through study completion, an average of 1 year

global longitudinal strain value is obtained by offline analysis of 2-dimensional Echocardiography, reduction of more than 15% in left ventricular systole suggests some degree of cardiotoxicity by European Society of Cardiology 2016

Concentration of Troponin I, troponin T, hypersensitive troponin, brain natriuretic peptide and NT-proBNP

时间窗: through study completion, an average of 1 year

These levels are measured with the Siemens ADVIA Centaur XP Immunoassay System, normal ranges of Troponin I, troponin T, hypersensitive troponin, brain natriuretic peptide and NT-proBNP are 0-0.03 ng/mL, 0-0.01 ng/mL, 0-0.04 ng/mL, 0-100 pg/mL, and 0-125pg/mL respectively

The average flow velocity of the anterior descending coronary artery

时间窗: through study completion, an average of 1 year

obtained by phase contrast magnetic resonance arteriography of cardiac magnetic resonance imaging

次要结局

未报告次要终点

研究者

发起方
Guizhou Medical University
申办方类型
Other
责任方
Sponsor

相似试验